UniPharma Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 105.39 million compared to TWD 138.64 million a year ago. Net loss was TWD 74.41 million compared to TWD 55.35 million a year ago. Basic loss per share from continuing operations was TWD 2.11 compared to TWD 1.57 a year ago. Diluted loss per share from continuing operations was TWD 2.11 compared to TWD 1.57 a year ago.